Advertisement

Endotoxin pp 413-415 | Cite as

Effects of Lipopolysaccharide or Recombinant Human-Interleukin-1β on Chemiluminescence by Peritoneal Macrophages from Normal and MRL-1pr/1pr Mice

  • C. Damais
  • L. Friteau
  • D. Lando
  • B. Dugas
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 256)

Abstract

Mononuclear phagocytes, under physiological conditions in a resting state, can be functionally activated by a number of stimuli (singly or in combination) both in vitro and in vivo. Amongst stimuli, some are known to prime macrophages for enhancing their level of oxidative metabolism revealed by luminol-dependent chemiluminescence (LDCL). Macrophage activation is a multi-step phenomenon which culminates to tumoricidal activity (5). This activation process is accompanied by synthesis of a variety of biologically active molecules such as Interleukin-1 (IL-1). Interleukin-1 released by macrophages can be induced in vitro by natural and synthetic bacterial immunoadjuvants such as lipopolysaccharide (LPS) (7) and Muramyl dipeptide (1). IL-1 is a polypeptide displaying a broad spectrum of biological activities (3). In this work, we compared the ability of LPS and recombinant human Interleukin-lβ (rHu-IL-1β) (Roussel-Uclaf) to prime in vivo murine peritoneal macrophage-LDCL of both normal (Balb/c and MRL-+/+) and MRL-1pr/1pr mice. MRL-1pr/lpr mice develop a systemic lupus erythematosus-like syndrome characterized by numbers of cellular and humoral abnormalities (6), such as an increase in absolute number of lymphocytes and macrophages as function of age (2, 4, 6). Peritoneal macrophages from this strain of mice spontaneously showed an increased expression of class II antigen, expression of Interleukin-2 receptor and exhibited an enhanced oxidative metabolism triggered by phorbol-ester (PMA) (2, 4).

Keywords

Peritoneal Macrophage Mononuclear Phagocyte Peritoneal Cell Prime Macrophage Tumoricidal Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Damais, C., Riveau, G., Parant, M., Gerota, J. and Chedid, L., 1982, Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated with muramyl dipeptide derivatives. Int. J. Immunopharmac. 4: 451.CrossRefGoogle Scholar
  2. 2.
    Dang-Vu, A. P., Pisetsky, D. S. and Weinberg, J. B., 1987, Functional alterations of macrophages in autoimmune MRL-1pr/lpr mice. J. Immunol. 138: 1757.PubMedGoogle Scholar
  3. 3.
    Dinarello, C. A., 1984, Interleukin-1. Rev. Infect. Dis. 6: 51.Google Scholar
  4. 4.
    Dugas, B., Lecaque, D., Lando, D., Secchi, J and Damais, C., 1988, Effect of in vivo injection of recombinant human Interleukin-2 on peritoneal macrophages from MRL-1pr/lpr mice. J. Autoimmunity in press.Google Scholar
  5. 5.
    Nathan, C. F., Murray, H. W. and Cohn, Z. A., 1980, The macrophage as an effector cell. N. Engl. J. Med. 303: 622.PubMedCrossRefGoogle Scholar
  6. 6.
    Theofilopoulos, A. N. and Dixon, F. J., 1981, Etiopathogenesis of murine SLE. Immunol. Rev. 55: 179.PubMedCrossRefGoogle Scholar
  7. 7.
    Weinberg, J. B., Chapman, H. A. and Hibbs, J. B., 1978, Characterization of the effects of endotoxin on macrophage tumor cell killing. J. Immunol. 121: 72.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • C. Damais
    • 1
  • L. Friteau
    • 2
  • D. Lando
    • 2
  • B. Dugas
    • 1
  1. 1.U313 INSERMHôpital Pitié-SalpētrièreParisFrance
  2. 2.Laboratoire d’ImmunologieRoussel-UclafRomainvilleFrance

Personalised recommendations